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Background
Myocardial T1 mapping is increasingly used to diagnose
and quantify disease burden in patients with known or
suspected cardiac amyloid. Optimal timing for diagnostic
application of T1 mapping is not established.
Methods
Myocardial T1 mapping was performed in two cohorts -
(1) “amyloid +” subjects, defined by biopsy-proven sys-
temic amyloid with associated remodeling suggestive of
cardiac involvement (left ventricular [LV] hypertrophy
and/or atrial dilation); (2) normative controls without
risk factors for amyloid or cardiovascular disease. CMR
(1.5T) included 2 components - cine-CMR (SSFP) for
cardiac structure/function, and T1 mapping for myocar-
dial tissue characterization. T1 mapping was performed
using a conventional modified look locker inversion
recovery (MOLLI) sequence (flip angle = 30°; matrix
256 × 128; parallel imaging reduction factor =1.5; linear
view ordering; 6 Kaiser-Bessel ramp preparation; 17
heart beat acquisition), with T1 calculated using an
established formula (T1 = T1* (B/A-1), T1*, A, and B
obtained via three-parameter exponential fit). To test
time dependent differences in myocardial T1, MOLLI
was acquired at sequential time points (3,5,10,14,
20 minutes) following intravenous administration of
gadolinium (0.2 mmol/kg).
Results
10 subjects (5 amyloid, 5 controls) were studied (44 ± 21
years, 40% male); all amyloid affected subjects had biopsy-
confirmed disease (4 light chain type, 1 transthyretin).
Amyloid subjects had higher LV mass (200 ± 34 vs. 101 ±
34 gm, p = 0.004), lower myocardial contraction fraction
(32 ± 8 vs. 88 ± 27, p = 0.002), and larger left atrial area
(26 ± 5 vs. 18 ± 5 cm2, p = 0.03) than controls, but similar
LV end-diastolic volume (120 ± 24 vs. 133 ± 45 ml, p =
0.61), stroke volume (66 ± 10 vs. 86 ± 30 ml, p = 0.20),
and LVEF (56 ± 10 vs. 65 ± 4%, p = 0.11). MOLLI was
successfully acquired in all subjects at each time point: T1
differed significantly (all p ≤ 0.05) between amyloid and
control groups at all times (Figure 1). However, magnitude
of difference temporally decreased following gadolinium
administration (Figure 2): T1 differences between patients
and controls were maximal at 3 minutes post-contrast
(135 ± 15 vs. 310 ± 61 msec, p = 0.004) with progressive
decrements thereafter, as evidenced by 57% relative differ-
ence between groups at 3 minutes and only a 36% differ-
ence at 20 minutes following gadolinium infusion.
Conclusions
MOLLI-quantified myocardial T1 yields maximal differ-
ence between amyloid-affected subjects and normative
controls within 3 minutes following gadolinium adminis-
tration. Increased magnitude of T1 difference early post
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contrast may relate to altered gadolinium contrast
kinetics due to amyloid-associated increases in cardiac
extracellular volume, and/or pulse-sequence aspects of
the MOLLI approach. Current findings support use of
early post-contrast MOLLI T1 mapping for identification
of cardiac amyloid.
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Figure 1 Mean +/- standard deviation T1 times for healthy controls and amyloid patients.
Figure 2 Percentage T1 difference relative to the healthy mean T1 time.
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